Restart Life Announces Collaboration with University of Manitoba's Centre for Food Technology and Research

Executive Summary

• Restart Life Sciences Corp. announced a scientific collaboration with the University of Manitoba’s Richardson Centre for Food Technology and Research (RCFTR) to support product development across its functional wellness portfolio.
• The company clarified terms of its previously announced CAD $250,000 loan financing, adding that 2,500,000 share purchase warrants at $0.10 per share will be issued to the lender, exercisable for two years.

Key Details

• Collaboration Scope: RCFTR will conduct scientific studies to validate formulations, optimize ingredient functionality, assess bioavailability, and evaluate stability for Restart Life’s BrainQ™, BrainBalls™ and Holy Crap™ product lines.
• Research Objectives: Include exploratory evaluations of ingredient quality, formulation integrity, sensory characteristics, nutrient retention, degradation patterns, and preliminary bioavailability assessments. Deliverables will be high‑level scientific observations, technical summaries, and recommendations.
• Strategic Rationale: The partnership aims to strengthen the scientific foundation of Restart Life’s functional foods targeting brain health, gut‑brain axis support, and overall vitality, enhancing product efficacy and quality as the company scales.
• Loan Financing Clarification (December 22 2025 announcement):
• Principal amount: CAD $250,000
• Interest rate: 12% per annum payable on the loan balance
• Additional consideration: issuance of 2,500,000 share purchase warrants to the lender
• Warrant exercise price: $0.10 per share
• Warrant term: two years from issuance
• CEO Quote: “Partnering with RCFTR gives us access to world‑class food science expertise and facilities…to ensure our products meet the highest standards of efficacy, consistency, and quality as we scale our functional wellness platform.” – Steve Loutskou, CEO.

Notable Quotes

• Steve Loutskou (CEO): “As we integrate Holy Crap™ products into our portfolio … it is essential that our innovation is grounded in rigorous scientific assessment.”
• Dr. Michael Janzen (RCFTR Research Development Manager): “We look forward to working closely with Restart Life Sciences as they advance their functional product lines.”